GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diagnostic Medical Systems (XPAR:ALDMS) » Definitions » Net Cash per Share

Diagnostic Medical Systems (XPAR:ALDMS) Net Cash per Share : €-1.75 (As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Diagnostic Medical Systems Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Diagnostic Medical Systems's Net Cash per Share for the quarter that ended in Dec. 2024 was €-1.75.

The historical rank and industry rank for Diagnostic Medical Systems's Net Cash per Share or its related term are showing as below:

XPAR:ALDMS's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 7.5
* Ranked among companies with meaningful Price-to-Net-Cash only.

Diagnostic Medical Systems Net Cash per Share Historical Data

The historical data trend for Diagnostic Medical Systems's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnostic Medical Systems Net Cash per Share Chart

Diagnostic Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.67 -1.87 -2.07 -1.97 -1.75

Diagnostic Medical Systems Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.07 -1.90 -1.97 -2.08 -1.75

Competitive Comparison of Diagnostic Medical Systems's Net Cash per Share

For the Medical Devices subindustry, Diagnostic Medical Systems's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnostic Medical Systems's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Diagnostic Medical Systems's Price-to-Net-Cash falls into.


;
;

Diagnostic Medical Systems Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Diagnostic Medical Systems's Net Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as

Net Cash per Share (A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(6.051-39.788-1.325)/20.030
=-1.75

Diagnostic Medical Systems's Net Cash per Share for the quarter that ended in Dec. 2024 is calculated as

Net Cash per Share (Q: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(6.051-39.788-1.325)/20.030
=-1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnostic Medical Systems  (XPAR:ALDMS) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Diagnostic Medical Systems Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Diagnostic Medical Systems's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnostic Medical Systems Business Description

Traded in Other Exchanges
Address
9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

Diagnostic Medical Systems Headlines

No Headlines